# DESCRIPTION

## FIELD OF THE INVENTION

- introduce Helicobacter pylori infection treatment

## BACKGROUND OF THE INVENTION

- describe Helicobacter pylori
- explain Helicobacter pylori infection
- discuss transmission route
- describe stomach protection
- explain urease function
- discuss immune response
- describe gastritis development
- link Helicobacter pylori to peptic ulcer
- link Helicobacter pylori to gastric cancer
- discuss cag pathogenicity island
- describe cagA oncoprotein
- introduce triple therapy
- describe proton pump inhibitors
- explain gastric proton pump mechanism
- discuss antibiotic treatment
- describe side effects
- discuss antibiotic resistance
- introduce alternative antibiotics
- discuss antioxidant micronutrients
- describe antibacterial effect of plant extracts
- introduce phenolic compounds
- discuss ferulic acid properties
- propose ferulic acid use
- introduce polysorbates
- describe polysorbate properties
- discuss prior art polysorbate use
- introduce international patent application
- discuss polysorbate antibacterial activity
- discuss prior art limitations

## SUMMARY OF THE INVENTION

- introduce new pharmaceutical preparations

## DETAILED DESCRIPTION OF THE INVENTION

- describe pharmaceutical compositions
- introduce polysorbate-antibiotic combination
- discuss synergistic activity
- describe preferred embodiments
- introduce clarithromycin and metronidazole
- discuss minimal bactericide concentrations
- prefer polysorbate 80
- discuss toxicity study
- establish NOAEL and ADI
- describe pharmaceutical preparation forms
- introduce syrup and granulate forms
- describe administration schedule
- introduce ferulic acid
- discuss antioxidant and antibacterial action
- describe sachet and syrup forms
- discuss ratio of active agents
- propose further use of active compounds
- discuss veterinary use

## EXAMPLES

- introduce examples of formulations

### Formulations Containing Clarithromycin, Metronidazole and Polysorbate 80

- describe preparation method of surfactant mixture
- describe preparation with polysorbate/antibiotics ratio: 1:5
- describe preparation with polysorbate/antibiotics ratio: 1:2.5
- describe preparation with polysorbate/antibiotics ratio: 1:1.25
- describe preparation with polysorbate/antibiotics ratio: 1:1
- describe preparation with polysorbate/antibiotics ratio: 1.25:1
- describe preparation with polysorbate/antibiotics ratio: 2:1 and 2.5:1

### Formulations Containing Metronidazole and Polysorbate 80

- describe preparation method

### Formulations Containing Clarithromycin and Polysorbate 80

- describe preparation method
- describe preparation with polysorbate/clarithromycin: 2:1
- describe preparation with polysorbate/clarithromycin: 3:1
- introduce evaluation of antibacterial activity
- describe sensitivity tests
- describe bacterial strains
- describe antibacterial activity tests
- describe test materials preparation
- describe sample preparation
- describe bacterial suspension preparation
- describe incubation and subculture
- describe minimal bactericidal concentration (MBC) determination
- present results in table
- discuss results
- describe synergistic activity of polysorbate
- describe additive activity of ferulic acid/polysorbate combination

